LUNG NON-SMALL CELL SQUAMOUS CARCINOMA
Clinical trials for LUNG NON-SMALL CELL SQUAMOUS CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LUNG NON-SMALL CELL SQUAMOUS CARCINOMA trials appear
Sign up with your email to follow new studies for LUNG NON-SMALL CELL SQUAMOUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Four-Drug attack on tough lung cancer
Disease control OngoingThis study is testing if adding a new drug called berzosertib to a standard three-drug treatment works better for people with advanced squamous cell lung cancer. The goal is to control the cancer, slow its growth, and help patients live longer. Researchers will compare the four-d…
Matched conditions: LUNG NON-SMALL CELL SQUAMOUS CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Can a One-Two punch of radiation and immune therapy better fight lung cancer?
Disease control OngoingThis study is testing if combining a targeted, high-dose radiation treatment with an immunotherapy drug works better than radiation alone for certain early-stage or recurrent non-small cell lung cancers. About 140 participants will be randomly assigned to receive either the radia…
Matched conditions: LUNG NON-SMALL CELL SQUAMOUS CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC